Why Is Guardant Health (GH) Stock Soaring Today [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
that real-world evidence from its InfinityAI platform contributed to the approval of the cancer drug ENHERTU® in Japan. The drug, developed by Daiichi Sankyo, was approved for treating patients with specific types of HER2-positive advanced or recurrent solid cancers. This development highlighted the increasing role of AI-powered, real-world data in the drug approval process, which could help get new treatments to patients faster. The news signaled a significant validation of Guardant's technology and its application in precision oncology. Is now the time to buy Guardant Health? Access our full analysis report here, it's free What Is The Market Telling Us Guardant Health's shares are very volatile and have had 26 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 4 days ago when the
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- 1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]Yahoo! Finance
- Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan [Yahoo! Finance]Yahoo! Finance
- Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in JapanBusiness Wire
- Why Guardant Health (GH) Stock Is Falling Today [Yahoo! Finance]Yahoo! Finance
- Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 2/19/26 - Beat
GH
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- GH's page on the SEC website